Position in HIMS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$224,800
-$20,230 QoQ
Shares Held
6,484
+50.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#344
of 504 holders
Holding Since
Mar 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Mar 31, 2025CallValue
$38,415
CallShares
1,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $1,567,354 across 8 Drug Manufacturers - Specialty & Generic names. HIMS ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,578 | $328,975 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
1,679 | $282,978 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
This page
|
6,484 | $224,800 | |
| 4 | HLN |
Haleon plc
|
19,789 | $184,631 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
10,045 | $180,408 | |
| 6 | VTRS |
Viatris Inc
|
10,836 | $172,075 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
10,141 | $162,560 | |
| 8 | CRON |
Cronos Group Inc.
|
11,125 | $30,927 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,800 | 6,484 | Shares | Sole | 2026-07-08 | |
| 2025-09-30 | $245,030 | 4,320 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $173,222 | 5,862 | Shares | Sole | 2025-04-30 | |
| 2025-03-31 | $38,415 | 1,300 | Call | Sole | 2025-04-30 | |
| 2021-03-31 | $26,460 | 2,000 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||